Expertise in
4
conditions

Christophe Mariette

Lille, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
4
conditions
Lille, FR 
OverviewLocationsClinical Research

Overview

Christophe Mariette practices in Lille, France. Mr. Mariette is highly rated in 4 conditions, according to our data. His top areas of expertise are Esophageal Cancer, Stomach Cancer, Gastroesophageal Reflux Disease (GERD), Pancreaticoduodenectomy, and Lymphadenectomy.

His clinical research consists of co-authoring 212 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Lille, France
Other Locations
Grenoble, France
Paris, France
Rennes, France
Besancon, France
Villeneuve-d'ascq, France
France
Boulevard De La Chantourne, La Tronche, 38700, France
Saint-claude-de-diray, France
Bordeaux, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Multicenter Randomized Controlled Trial to Evaluate the Strategy of Primary Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma (ADCI002 Study)
Multicenter Randomized Controlled Trial to Evaluate the Strategy of Primary Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma (ADCI002 Study)
Enrollment Status: Recruiting
Publish Date: January 26, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
GASTRICHIP : D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma. A Randomized and Multicentric Phase III Study.
GASTRICHIP : D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma. A Randomized and Multicentric Phase III Study.
Enrollment Status: Active_not_recruiting
Publish Date: May 08, 2024
Intervention Type: Procedure, Drug
Study Drug: HIPEC with oxaliplatin
Study Phase: Phase 3
PReoperative Chemoradiation With Paclitaxel-carboplatin or With Fluorouracil-oxaliplatine-acide Folinique (FOLFOX) for Resectable Esophageal and Junctional Cancer - A Randomized Phase II Trial
PReoperative Chemoradiation With Paclitaxel-carboplatin or With Fluorouracil-oxaliplatine-acide Folinique (FOLFOX) for Resectable Esophageal and Junctional Cancer - A Randomized Phase II Trial
Enrollment Status: Completed
Publish Date: February 28, 2024
Intervention Type: Drug
Study Drugs: FOLFOX, CarboP-pacliT
Study Phase: Phase 2
Neo-AEGIS (NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study): Randomised Clinical Trial of Neoadjuvant and Adjuvant Chemotherapy (Modified MAGIC or FLOT Regimen) vs. Neoadjuvant Chemoradiation (CROSS Protocol) in Adenocarcinoma of the Oesophagus and Oesophago-gastric Junction
Neo-AEGIS (NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study): Randomised Clinical Trial of Neoadjuvant and Adjuvant Chemotherapy (Modified MAGIC or FLOT Regimen) vs. Neoadjuvant Chemoradiation (CROSS Protocol) in Adenocarcinoma of the Oesophagus and Oesophago-gastric Junction
Enrollment Status: Completed
Publish Date: September 30, 2022
Intervention Type: Radiation, Drug
Study Drugs: Epirubicin, Cisplatin / Oxaliplatin, 5 Flourouracil/ Capecitabine, Paclitaxel, Carboplatin, Docetaxel, Oxaliplatin, Leucovorin, 5-Fluorouracil
Study Phase: Phase 3
Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer - a Multicenter, Prospective, Open-labeled, Two-armed, Randomized, Controlled Phase III Trial
Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer - a Multicenter, Prospective, Open-labeled, Two-armed, Randomized, Controlled Phase III Trial
Enrollment Status: Unknown
Publish Date: March 17, 2022
Intervention Type: Procedure, Drug
Study Drugs: Preoperative Chemotherapy, Postoperative Chemotherapy
Study Phase: Phase 3
Use of Biological Mesh Versus Standard Wound Care in Infected Incisional Ventral Hernias: a Multicenter Randomized Controlled Trial, the SIMBIOSE Study
Use of Biological Mesh Versus Standard Wound Care in Infected Incisional Ventral Hernias: a Multicenter Randomized Controlled Trial, the SIMBIOSE Study
Enrollment Status: Completed
Publish Date: August 06, 2019
Intervention Type: Biological, Procedure
Study Phase: Phase 3
View 5 Less Clinical Trials

212 Total Publications

Real-Life Management of Patients Aged 80 Years Old and Over With Multiple Myeloma: Results of the EMMY Cohort.
Real-Life Management of Patients Aged 80 Years Old and Over With Multiple Myeloma: Results of the EMMY Cohort.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 13, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mariette's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile